TIAA CREF INVESTMENT MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$6,416,000
+4.3%
183,119
-1.1%
0.01%0.0%
Q4 2018$6,149,000
-67.3%
185,087
-50.5%
0.01%
-16.7%
Q3 2018$18,820,000
+60.1%
373,796
+90.3%
0.01%
-25.0%
Q2 2018$11,758,000
+31.4%
196,454
+0.5%
0.01%
+33.3%
Q1 2018$8,949,000
+89.0%
195,394
+64.4%
0.01%
+100.0%
Q4 2017$4,735,000
-31.8%
118,832
-31.5%
0.00%
-40.0%
Q3 2017$6,940,000
-29.8%
173,500
-24.4%
0.01%
-28.6%
Q2 2017$9,892,000
+40.5%
229,505
+2.0%
0.01%
+40.0%
Q1 2017$7,040,000
+19.8%
224,934
-3.3%
0.01%
+25.0%
Q4 2016$5,875,000
-1.8%
232,654
-3.9%
0.00%0.0%
Q3 2016$5,985,000
+16.9%
242,011
-3.7%
0.00%0.0%
Q2 2016$5,120,000
+75.8%
251,350
+31.6%
0.00%
+100.0%
Q1 2016$2,912,000
+55.5%
190,959
+37.0%
0.00%
+100.0%
Q4 2015$1,873,000
-8.7%
139,379
-4.7%
0.00%
-50.0%
Q3 2015$2,052,000
-3.6%
146,235
+16.6%
0.00%0.0%
Q2 2015$2,129,000
+73.2%
125,390
+23.3%
0.00%
+100.0%
Q1 2015$1,229,000
+45.6%
101,6890.0%0.00%0.0%
Q4 2014$844,000
-16.8%
101,689
-12.8%
0.00%0.0%
Q3 2014$1,014,000
-29.5%
116,661
-11.3%
0.00%0.0%
Q2 2014$1,439,000
+93.4%
131,461
+58.0%
0.00%0.0%
Q1 2014$744,000
+66.4%
83,214
+40.5%
0.00%
Q4 2013$447,000
-8.0%
59,225
-10.8%
0.00%
Q3 2013$486,000
+36.1%
66,365
+19.5%
0.00%
Q2 2013$357,00055,5360.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders